Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings that could lead to a therapy ...

The start of any new gene therapy trial is an exciting and nervous time. But for the participants and doctors involved in the recently launched trial for Duchenne Muscular Dystrophy (DMD) at Columbus ...

COLUMBUS, Ohio – A 36-year-old traffic controller has received a gene therapy injection for muscular dystrophy, testing a possible treatment for the debilitating disease. The Muscular Dystrophy ...

Peptides, short chains of amino acids, play key roles in the body. FDA-approved drugs like insulin and GLP-1 medications are ...

In this systematic review of the literature, we summarized publications on onabotulinumtoxinA injections in adult patients treated for upper- or lower-limb spasticity. Our goal was to review the ...

Researchers in Canada have evaluated the effect of the implantation of donor muscle precursor cells (MPCs) on the expression of dystrophin in patients with Duchenne muscular dystrophy. In nine ...

The advantage of this treatment is the local administration, on the site of muscle hyperactivity, without the generalised effects of muscle relaxants that are orally administered and therefore can ...

April 12, 2011 (Washington, DC) — Muscle tendon injections might be an effective treatment for patients who have residual pain with radiculopathy after epidural corticosteroids, facet blocks, or ...

November 27, 2012 — Ottawa — Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings ...